Molecular basis for the Apparent Mineralocorticoid Excess Syndrome in the Oman population

Molecular and Cellular Endocrinology

Volumn 217, Issue 1-2, 2004, Pages 143-149

  Quinkler, M ^a   Bappal, B ^b   Draper, N ^a   Atterbury, A J ^a   Lavery, G G ^a   Walker, E A ^a   DeSilva, V ^b   Taylor, N F ^c   Hala, S ^b   Rajendra, N ^b   Stewart, P M ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b ROYAL HOSPITAL   (Oman)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

11 HSD2; AME syndrome; Cortisol; Hypertension; Hypokalaemia; Oman

Indexed keywords

HYDROXYSTEROID DEHYDROGENASE; ISOENZYME; MINERALOCORTICOID;

APPARENT MINERALOCORTICOID EXCESS SYNDROME; AUTOSOMAL RECESSIVE DISORDER; AUTOSOMAL RECESSIVE INHERITANCE; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; EXON; FAMILIAL DISEASE; FEMALE; GENE MUTATION; GENE SEQUENCE; GENETIC DISORDER; HUMAN; HYPERTENSION; INFANT; MALE; MOLECULAR BIOLOGY; NEWBORN; OMAN; POPULATION RESEARCH; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL;

11-BETA-HYDROXYSTEROID DEHYDROGENASES; CASE-CONTROL STUDIES; CHILD, PRESCHOOL; CORTISONE; EXONS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERTENSION; INFANT; MALE; MINERALOCORTICOIDS; MUTATION; OMAN; PEDIGREE; PREDICTIVE VALUE OF TESTS;

EID: 20244385677     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2003.10.019     Document Type: Conference Paper

References (22)

1. Agarwal A.K., Rogerson F.M., Mune T., White P.C. Analysis of the human gene encoding the kidney isozyme of 11b-hydroxysteroid dehydrogenase. J. Steroid Biochem. Mol. Biol. 55:1995;473-479
2. Arriza J.L., Weinberger C., Cerelli G., Glaser T.M., Handelin B.L., Housman D.E., Evans R.M. Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor. Science. 237(4812):1987;268-275
3. Edwards C.R., Stewart P.M., Burt D., Brett L., McIntyre M.A., Sutanto W.S., de Kloet E.R., Monder C. Localisation of 11b-hydroxysteroid dehydrogenase - tissue specific protector of the mineralocorticoid receptor. Lancet. 2(8618):1988;986-989
4. Funder J.W., Pearce P.T., Smith R., Smith A.I. Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated. Science. 242(4878):1988;583-585
5. Krozowski Z.S., Funder J.W. Renal mineralocorticoid receptors and hippocampal corticosterone-binding species have identical intrinsic steroid specificity. Proc. Natl. Acad. Sci. U.S.A. 80(19):1983;6056-6060
6. Lavery G., Ronconi V., Draper N., Rabbitt E.H., Lyons V., Chapman K.E., Walker E.A., McTernan C.L., Giacchetti G., Mantero F., Seckl J.R., Edwards C.R.W., Connell J.M.C., Hewison M., Stewart P.M. Late onset apparent mineralocorticoid excess due to novel compound heterozygous mutations in the HSD11B2 gene. Hypertension. 42(2):2003;123-129
7. Monder C., Shackleton C.H., Bradlow H.L., New M.I., Stoner E., Iohan F., Lakshmi V. The syndrome of apparent mineralocorticoid excess: its association with 11b-dehydrogenase and 5b-reductase deficiency and some consequences for corticosteroid metabolism. J. Clin. Endocrinol. Metab. 63(3):1986;550-557
8. Mune T., Rogerson F.M., Nikkilä H., Agarwal A.K., White P.C. Human hypertension caused by mutations in the kidney isozyme of 11b-hydroxysteroid dehydrogenase. Nat. Genet. 10:1995;394-399
9. New M.I., Levine L.S., Biglieri E.G., Pareira J., Ulick S. Evidence for an unidentified steroid in a child with apparent mineralocorticoid hypertension. J. Clin. Endocrinol. Metab. 44(5):1977;924-933
10. Nunez B.S., Rogerson F.M., Mune T., Igarashi Y., Nakagawa Y., Phillipov G., Moudgil A., Travis L.B., Palermo M., Shackleton C., White P.C. Mutants of 11b-hydroxysteroid dehydrogenase (11b-HSD2) with partial activity: improved correlations between genotype and biochemical phenotype in apparent mineralocorticoid excess. Hypertension. 34:1999;638-642
11. Odermatt A., Dick B., Arnold P., Zaehner T., Plueschke V., Deregibus M.N., Repetto H., Frey B.M., Frey F.J., Ferrari P. A mutation in the cofactor-binding domain of 11b-hydroxysteroid dehydrogenase type 2 associated with mineralocorticoid hypertension. J. Clin. Endocrinol. Metab. 86(3):2001;1247-1252
12. Quinkler M., Stewart P.M. Hypertension and the Cortisol-Cortisone Shuttle. J. Clin. Endocrinol. Metab. 88(6):2003;2384-2392
13. Raven P.W., Taylor N.F. Sex differences in the human metabolism of cortisol. Endocr. Res. 22(4):1996;751-755
14. Raven P.W., Checkley S.A., Taylor N.F. Extra-adrenal effects of metyrapone include inhibition of the 11-oxoreductase activity of 11b-hydroxysteroid dehydrogenase: a model for 11b-HSD I deficiency. Clin. Endocrinol. (Oxf.). 43:1995;637-644
15. Shackleton C.H., Rodriguez J., Arteaga E., Lopez J.M., Winter J.S. Congenital 11b-hydroxysteroid dehydrogenase deficiency associated with juvenile hypertension: corticosteroid metabolite profiles of four patients and their families. Clin. Endocrinol. (Oxf.). 22(6):1985;701-712
16. Stewart P.M., Krozowski Z. 11b-hydroxysteroid dehydrogenase. Vitam. Horm. 57:1999;249-324
17. Stewart P.M., Krozowski Z.S., Gupta A., Milford D.V., Howie A.J., Sheppard M.C., Whorwood C.B. Hypertension in the syndrome of apparent mineralocorticoid excess due to mutation of the 11b-hydroxysteroid dehydrogenase type 2 gene. Lancet. 347:1996;88-91
18. Ulick S., Ramirez L.C., New M.I. An abnormality in steroid reductive metabolism in a hypertensive syndrome. J. Clin. Endocrinol. Metab. 44(4):1977;799-802
19. Werder E., Zachmann M., Vollmin J.A., Veyrat R., Prader A. Unusual steroid excretion in a child with low renin hypertension. Res. Steroids. 6:1974;385-389
20. White P.C., Mune T., Agarwal A.K. 11b-Hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess. Endocr. Rev. 18(1):1997;135-156
21. Wilson R.C., Harbison M.D., Krozowski Z.S., Funder J.W., Shackleton C.H.L., Hanauske-Abel H.M., Wei J.Q., Hertecant J., Moran A., Neiberger R.E., Balfe J.W., Fattah A., Daneman D., Licholai T., New M.I. Several homozygous mutations in the gene for 11b-hydroxysteroid dehydrogenase type 2 in patients with apparent mineralocorticoid excess. J. Clin. Endocrinol. Metab. 80:1995a;3145-3150
22. Wilson R.C., Krozowski Z.S., Li K., Obeyesekere V.R., Razzaghy Azar M., Harbison M.D., Wei J.Q., Shackleton C.H., Funder J.W., New M.I. A mutation in the HSD11B2 gene in a family with apparent mineralocorticoid excess. J. Clin. Endocrinol. Metab. 80(7):1995b;2263-2266